The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
Open accessAbstract
Almost all patients with hepatocellular carcinoma (HCC), a major type of primary liver cancer, also have liver cirrhosis, the severity of which hampers effective treatment for HCC despite recent progress in the efficacy of anticancer drugs for advanced stages of HCC. Here, we review recent knowledge concerning the molecular mechanisms of liver cirrhosis and its progression to HCC from genetic and epigenomic points of view. Because ~70% of patients with HCC have hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection, we focused on HBV- and HCV-associated HCC. The literature suggests that genetic and epigenetic factors, such as microRNAs, play a role in liver cirrhosis and its progression to HCC, and that HBV- and HCV-encoded proteins appear to be involved in hepatocarcinogenesis. Further studies are needed to elucidate the mechanisms, including immune checkpoints and molecular targets of kinase inhibitors, associated with liver cirrhosis and its progression to HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Shao, J., Cao, J., Liu, Y., Mei, H., Zhang, Y., & Xu, W. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.10.009 · Cited by 30
RetractedLi, G., Zhang, W., Gong, L., & Huang, X. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504017x15016337254623 · Cited by 27
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Leach, D. R., Krummel, M. F., & Allison, J. P. (1996) · Science · doi:10.1126/science.271.5256.1734 · Cited by 3,955
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Iwai, Y., Ishida, M., Tanaka, Y., Okazaki, T., Honjo, T., & Minato, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192461099 · Cited by 3,203
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Bruix, J., Reig, M., & Sherman, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.12.041 · Cited by 1,694
PD-1 and PD-1 ligands: from discovery to clinical application
Okazaki, T., & Honjo, T. (2007) · International Immunology · doi:10.1093/intimm/dxm057 · Cited by 1,310
Schachter, J., Ribas, A., Long, G. V., Arance, A., Grob, J.-J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C., Lotem, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31601-x · Cited by 1,225
The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
Moriya, K., Fujie, H., Shintani, Y., Yotsuyanagi, H., Tsutsumi, T., Ishibashi, K., Matsuura, Y., Kimura, S., Miyamura, T., & Koike, K. (1998) · Nature Medicine · doi:10.1038/2053 · Cited by 1,206
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Kim, C.-M., Koike, K., Saito, I., Miyamura, T., & Jay, G. (1991) · Nature · doi:10.1038/351317a0 · Cited by 1,158
Yoshida, H., Shiratori, Y., Moriyama, M., Arakawa, Y., Ide, T., Sata, M., Inoue, O., Yano, M., Tanaka, M., Fujiyama, S., et al. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00003 · Cited by 1,096
Self-citationHuman hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., O’Byrne, S. M., Blaner, W. S., Mukherjee, P., Friedman, S. L., & Eng, F. J. (2005) · Gut · doi:10.1136/gut.2004.042127 · Cited by 1,014
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Sung, W.-K., Zheng, H., Li, S., Chen, R., Liu, X., Li, Y., Lee, N. P., Lee, W. H., Ariyaratne, P. N., Tennakoon, C., et al. (2012) · Nature Genetics · doi:10.1038/ng.2295 · Cited by 991
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Totoki, Y., Tatsuno, K., Covington, K. R., Ueda, H., Creighton, C. J., Kato, M., Tsuji, S., Donehower, L. A., Slagle, B. L., Nakamura, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3126 · Cited by 781 · cited 4×
“TERT Telomerase reverse transcriptase TERT [52–56] CTNNB1 Catenin β1 β-catenin [52,53] TP53 Tumor protein p53 p53–RB [52,53] ARID2 AT-rich interaction domain 2 Chromatin remodeling [52] AXIN1 Axin 1 β-catenin [52] TSC2 TSC complex subunit 2 PI3K–mTOR [52] RB1 Retinoblastoma 1 p53–RB [52] ACVR2A Activin A receptor type…”
BackgroundInfluentialEssential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver
Hsu, S.-H., Wang, B., Kota, J., Yu, J., Costinean, S., Kutay, H., Yu, L., Bai, S., La Perle, K., Chivukula, R. R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63539 · Cited by 774
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Self-citationNault, J. C., Mallet, M., Pilati, C., Calderaro, J., Bioulac-Sage, P., Laurent, C., Laurent, A., Cherqui, D., Balabaud, C., & Zucman-Rossi, J. (2013) · Nature Communications · doi:10.1038/ncomms3218 · Cited by 695
Fujimoto, A., Furuta, M., Totoki, Y., Tsunoda, T., Kato, M., Shiraishi, Y., Tanaka, H., Taniguchi, H., Kawakami, Y., Ueno, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3547 · Cited by 689
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
Liaw, Y.-F., Tai, D.-I., Chu, C.-M., & Chen, T.-J. (1988) · Hepatology · doi:10.1002/hep.1840080310 · Cited by 612
Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
Inami, Y., Waguri, S., Sakamoto, A., Kouno, T., Nakada, K., Hino, O., Watanabe, S., Ando, J., Iwadate, M., Yamamoto, M., et al. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102031 · Cited by 604
Harding, J. J., Nandakumar, S., Armenia, J., Khalil, D. N., Albano, M., Ly, M., Shia, J., Hechtman, J. F., Kundra, R., El Dika, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2293 · Cited by 602 · cited 1×
“In sorafenib-treated patients with HCC, oncogenic PI3K–mTOR-pathway alterations are associated with lower disease-control rates and decreased median progression-free survival and overall survival [66].”
BackgroundKawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63408-6 · Cited by 536
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Clinical, Laboratory and Histological Associations in Adults with Nonalcoholic Fatty Liver Disease†
Neuschwander-Tetri, B. A., Clark, J. M., Bass, N. M., Van Natta, M. L., Unalp-Arida, A., Tonascia, J., Zein, C. O., Brunt, E. M., Kleiner, D. E., McCullough, A. J., et al. (2010) · Hepatology · doi:10.1002/hep.23784 · Cited by 463
Li, L.-M., Hu, Z.-B., Zhou, Z.-X., Chen, X., Liu, F.-Y., Zhang, J.-F., Shen, H.-B., Zhang, C.-Y., & Zen, K. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1001 · Cited by 451
Mason, W. S., Gill, U. S., Litwin, S., Zhou, Y., Peri, S., Pop, O., Hong, M. L. W., Naik, S., Quaglia, A., Bertoletti, A., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.012 · Cited by 449
Takano, S., Yokosuka, O., Imazeki, F., Tagawa, M., & Omata, M. (1995) · Hepatology · doi:10.1002/hep.1840210308 · Cited by 432
Self-citationInactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Li, M., Zhao, H., Zhang, X., Wood, L. D., Anders, R. A., Choti, M. A., Pawlik, T. M., Daniel, H. D., Kannangai, R., Offerhaus, G. J. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.903 · Cited by 427
Wong, Q. W. –., Lung, R. W. –., Law, P. T. –., Lai, P. B. –., Chan, K. Y. –., To, K., & Wong, N. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.003 · Cited by 424
Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease
Sumi, H., Yokosuka, O., Seki, N., Arai, M., Imazeki, F., Kurihara, T., Kanda, T., Fukai, K., Kato, M., & Saisho, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50036 · Cited by 403
Self-citationRay, R. B., Lagging, L. M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
Huang, J., Deng, Q., Wang, Q., Li, K.-Y., Dai, J.-H., Li, N., Zhu, Z.-D., Zhou, B., Liu, X.-Y., Liu, R.-F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2391 · Cited by 385
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway
Kekulé, A. S., Lauer, U., Weiss, L., Luber, B., & Hofschneider, P. H. (1993) · Nature · doi:10.1038/361742a0 · Cited by 369
Clouston, A. D., Powell, E. E., Walsh, M. J., Richardson, M. M., Demetris, A. J., & Jonsson, J. R. (2005) · Hepatology · doi:10.1002/hep.20650 · Cited by 361
Zhang, X., Liu, S., Hu, T., Liu, S., He, Y., & Sun, S. (2009) · Hepatology · doi:10.1002/hep.23008 · Cited by 355
Huang, J., Wang, Y., Guo, Y., & Sun, S. (2010) · Hepatology · doi:10.1002/hep.23660 · Cited by 342
Ohata, K., Hamasaki, K., Toriyama, K., Matsumoto, K., Saeki, A., Yanagi, K., Abiru, S., Nakagawa, Y., Shigeno, M., Miyazoe, S., et al. (2003) · Cancer · doi:10.1002/cncr.11427 · Cited by 322
Zhang, Y., Wei, W., Cheng, N., Wang, K., Li, B., Jiang, X., & Sun, S. (2012) · Hepatology · doi:10.1002/hep.25849 · Cited by 300
Steatosis affects chronic hepatitis C progression in a genotype specific way
Rubbia-Brandt, L., Fabris, P., Paganin, S., Leandro, G., Male, P.-J., Giostra, E., Carlotto, A., Bozzola, L., Smedile, A., & Negro, F. (2004) · Gut · doi:10.1136/gut.2003.018770 · Cited by 297
Qi, P., Cheng, S.-Q., Wang, H., Li, N., Chen, Y.-F., & Gao, C.-F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028486 · Cited by 290
Westin, J., Nordlinder, H., Lagging, M., Norkrans, G., & Wejstål, R. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00299-4 · Cited by 280
Suppression of Apoptotic Cell Death by Hepatitis C Virus Core Protein
Ray, R. B., Meyer, K., & Ray, R. (1996) · Virology · doi:10.1006/viro.1996.0644 · Cited by 265
Obi, S., Yoshida, H., Toune, R., Unuma, T., Kanda, M., Sato, S., Tateishi, R., Teratani, T., Shiina, S., & Omata, M. (2006) · Cancer · doi:10.1002/cncr.21832 · Cited by 262
Self-citationMajumder, M., Ghosh, A. K., Steele, R., Ray, R., & Ray, R. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1401-1407.2001 · Cited by 255
Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis
Xu, X., Fan, Z., Kang, L., Han, J., Jiang, C., Zheng, X., Zhu, Z., Jiao, H., Lin, J., Jiang, K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64265 · Cited by 248
Liaw, Y.-F., Chen, Y.-C., Sheen, I.-S., Chien, R.-N., Yeh, C.-T., & Chu, C.-M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.01.011 · Cited by 243
Chen, M. T., Billaud, J.-N., Sällberg, M., Guidotti, L. G., Chisari, F. V., Jones, J., Hughes, J., & Milich, D. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406282101 · Cited by 241
Staib, F., Perwez Hussain, S., Hofseth, L. J., Wang, X. W., & Harris, C. C. (2003) · Human Mutation · doi:10.1002/humu.10176 · Cited by 241
Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma
Bartolini, D., Dallaglio, K., Torquato, P., Piroddi, M., & Galli, F. (2018) · Translational Research · doi:10.1016/j.trsl.2017.11.007 · Cited by 235
Cha, M.-Y., Kim, C.-M., Park, Y.-M., & Ryu, W.-S. (2004) · Hepatology · doi:10.1002/hep.20245 · Cited by 220
Wang, Y., Lu, Y., Toh, S. T., Sung, W.-K., Tan, P., Chow, P., Chung, A. Y. F., Jooi, L. L. P., & Lee, C. G. L. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.043 · Cited by 219
Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins
Chen, M., Sällberg, M., Hughes, J., Jones, J., Guidotti, L. G., Chisari, F. V., Billaud, J.-N., & Milich, D. R. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3016-3027.2005 · Cited by 206
Lan, S.-H., Wu, S.-Y., Zuchini, R., Lin, X.-Z., Su, I.-J., Tsai, T.-F., Lin, Y.-J., Wu, C.-T., & Liu, H.-S. (2014) · Hepatology · doi:10.1002/hep.26659 · Cited by 180
Petta, S., Cammà, C., Marco, V. D., Alessi, N., Cabibi, D., Caldarella, R., Licata, A., Massenti, F., Tarantino, G., Marchesini, G., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01813.x · Cited by 179
KAKUMU, S., OKUMURA, A., ISHIKAWA, T., YANO, M., ENOMOTO, A., NISHIMURA, H., YOSHIOKA, K., & YOSHIKAI, Y. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4861382.x · Cited by 174
Hepatitis B Virus-Associated Hepatocellular Carcinoma
Xie, Y. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5765-6_2 · Cited by 173
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Kudo, M. (2018) · Cancers · doi:10.3390/cancers10110412 · Cited by 172
Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53
Fei, Q., Shang, K., Zhang, J., Chuai, S., Kong, D., Zhou, T., Fu, S., Liang, Y., Li, C., Chen, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms9651 · Cited by 169
Banerjee, S., Saito, K., Ait-Goughoulte, M., Meyer, K., Ray, R. B., & Ray, R. (2008) · Journal of Virology · doi:10.1128/jvi.01672-07 · Cited by 168
Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease
Kojima, H., Yokosuka, O., Imazeki, F., Saisho, H., & Omata, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024303 · Cited by 162
Self-citationWong, C., Wei, L., Law, C., Ho, D. W., Tsang, F. H., Au, S. L., Sze, K. M., Lee, J. M., Wong, C. C., & Ng, I. O. (2016) · Hepatology · doi:10.1002/hep.28304 · Cited by 162
Gao, P., Wong, C. C., Tung, E. K. K., Lee, J. M., Wong, C., & Ng, I. O. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.023 · Cited by 152
Wang, C., Yang, W. K., Yan, H., Luo, T., Zhang, J., Tang, L. V., Wu, F., Zhang, H., Yu, L., Zheng, L., et al. (2011) · Hepatology · doi:10.1002/hep.24675 · Cited by 149
Hepatitis C virus core protein represses p21WAF1/Cip1/Sid1 promoter activity
Ray, R. B., Steele, R., Meyer, K., & Ray, R. (1998) · Gene · doi:10.1016/s0378-1119(98)00030-4 · Cited by 147
Li, C., Wang, Y., Wang, S., Wu, B., Hao, J., Fan, H., Ju, Y., Ding, Y., Chen, L., Chu, X., et al. (2012) · Journal of Virology · doi:10.1128/jvi.02831-12 · Cited by 147
Kamel, M. M., Matboli, M., Sallam, M. M., Montasser, I. F., Saad, A. S., & El‐Tawdi, A. (2015) · Translational research · doi:10.1016/j.trsl.2015.10.002 · Cited by 141
Bose, S. K., Shrivastava, S., Meyer, K., Ray, R. B., & Ray, R. (2012) · Journal of Virology · doi:10.1128/jvi.00050-12 · Cited by 130
Miyamoto, H., Moriishi, K., Moriya, K., Murata, S., Tanaka, K., Suzuki, T., Miyamura, T., Koike, K., & Matsuura, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01683-06 · Cited by 127
Wang, C., Wang, Y., Chun-guang, F., Xu, F., Sun, W., Liu, Y., & Jia, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.191 · Cited by 125
Tanaka, S., & Wands, J. R. (1996) · PubMed · Cited by 122
Yaginuma, K., Kobayashi, H., Kobayashi, M., Morishima, T., Matsuyama, K., & Koike, K. (1987) · Journal of Virology · doi:10.1128/jvi.61.6.1808-1813.1987 · Cited by 119
Braconi, C., Valeri, N., Gasparini, P., Huang, N., Taccioli, C., Nuovo, G. J., Suzuki, T., Croce, C. M., & Patel, T. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2123 · Cited by 119
Liu, F.-Y., Zhou, S.-J., Deng, Y.-L., Zhang, Z.-Y., Zhang, E.-L., Wu, Z.-B., Huang, Z.-Y., & Chen, X.-P. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.46 · Cited by 114
Imazeki, F., Yokosuka, O., Fukai, K., Kanda, T., Kojima, H., & Saisho, H. (2008) · Liver International · doi:10.1111/j.1478-3231.2007.01630.x · Cited by 111
Self-citationProgression of liver fibrosis among injection drug users with chronic hepatitis C†
Wilson, L. E., Torbenson, M. S., Astemborski, J. A., Faruki, H., Spoler, C., Rai, R., Mehta, S. H., Kirk, G. D., Nelson, K. E., Afdhal, N. H., et al. (2006) · Hepatology · doi:10.1002/hep.21091 · Cited by 111
Serum miR-18a: A Potential Marker for Hepatitis B Virus-Related Hepatocellular Carcinoma Screening
Li, L., Guo, Z., Wang, J., Mao, Y., & Gao, Q. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2317-y · Cited by 105
Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling
Kanda, T., Steele, R., Ray, R., & Ray, R. B. (2008) · Journal of Virology · doi:10.1128/jvi.01300-08 · Cited by 101
Self-citationKumar, D. B. U., Chen, C., Liu, J.-C., Feldman, D. E., Sher, L. S., French, S. W., DiNorcia, J., French, S. W., Naini, B. V., Junrungsee, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.11.002 · Cited by 100
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Yang, Y., Chen, W., Tsan, Y., Chen, M., Shih, W., Tsai, Y., & Chen, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.07.006 · Cited by 93
Nrf2, but not β‐catenin, mutation represents an early event in rat hepatocarcinogenesis
Zavattari, P., Perra, A., Menegon, S., Kowalik, M. A., Petrelli, A., Angioni, M. M., Follenzi, A., Quagliata, L., Ledda‐Columbano, G. M., Terracciano, L., et al. (2015) · Hepatology · doi:10.1002/hep.27790 · Cited by 91
Zhao, Q., Li, T., Qi, J., Liu, J., & Qin, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109782 · Cited by 90
Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks
Kennedy, P. T. F., Litwin, S., Dolman, G. E., Bertoletti, A., & Mason, W. S. (2017) · Viruses · doi:10.3390/v9050096 · Cited by 89
El-Abd, N., Fawzy, N., Elsheikh, S., & Soliman, M. (2015) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-015-0148-1 · Cited by 83
miR-22 Promotes HBV-Related Hepatocellular Carcinoma Development in Males
Jiang, R., Deng, L., Zhao, L., Li, X., Zhang, F., Xia, Y., Gao, Y., Wang, X., & Sun, B. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1734 · Cited by 83
Haga, Y., Kanda, T., Sasaki, R., Nakamura, M., Nakamoto, S., & Yokosuka, O. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i46.12989 · Cited by 79
Self-citationMiR-221 accentuates IFN׳s anti-HCV effect by downregulating SOCS1 and SOCS3
Xu, G., Yang, F., Ding, C., Wang, J., Zhao, P., Wang, W., & Ren, H. (2014) · Virology · doi:10.1016/j.virol.2014.06.024 · Cited by 76
The PreS2 Activators of the Hepatitis B Virus: Activators of Tumour Promoter Pathways
Hildt, E., & HOFSCHNEIDER, P. H. (1998) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-46870-4_23 · Cited by 73
Keng, V. W., Tschida, B. R., Bell, J. B., & Largaespada, D. A. (2010) · Hepatology · doi:10.1002/hep.24091 · Cited by 73
Longato, L., de la Monte, S. M., Kuzushita, N., Horimoto, M., Rogers, A. B., Slagle, B. L., & Wands, J. R. (2009) · Hepatology · doi:10.1002/hep.22856 · Cited by 73
Zhang, H., Zhu, C., Zhao, Y. C., Li, M., Wu, L., Yang, X., Wan, X., Wang, A., Zhang, M. Q., Sang, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6087 · Cited by 72
Kodama, T., Newberg, J. Y., Kodama, M., Rangel, R., Yoshihara, K., Tien, J. C.-Y., Parsons, P. H., Wu, H., Finegold, M. J., Copeland, N. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606876113 · Cited by 72
Banerjee, A. K., Meyer, K., Mazumdar, B., Ray, R. B., & Ray, R. (2010) · Journal of Virology · doi:10.1128/jvi.02344-09 · Cited by 70
Virus-induced hepatocellular carcinoma with special emphasis on HBV
Wang, M., Dong, X., & Ning, Q. (2017) · Hepatology International · doi:10.1007/s12072-016-9779-5 · Cited by 70
Viral Biomarkers in Chronic HBeAg Negative HBV Infection
Hadziyannis, E. S., & Laras, A. (2018) · Genes · doi:10.3390/genes9100469 · Cited by 70
Dyal, H. K., Aguilar, M. E. F., Bhuket, T. P., Liu, B., Holt, E. W., Torres, S., Cheung, R. C., & Wong, R. J. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3760-3 · Cited by 69
Bai, P., Xia, N., Sun, H., & Kong, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13213 · Cited by 67
Chang, S., Fann, C. S. J., Su, W.-H., Wang, Y. C., Weng, C.-C., Yu, C., Hsu, C., Hsieh, A., Chien, R., Chu, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099724 · Cited by 66
Sheng, Y., Li, J., Zou, C., Wang, S., Cao, Y., Zhang, J., Huang, A., & Tang, H. (2014) · Archives of Virology · doi:10.1007/s00705-014-2084-5 · Cited by 64
Pezzuto, F., Buonaguro, L., Buonaguro, F. M., & Tornesello, M. L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041007 · Cited by 64
Diagnostic and prognostic significance of serum miR-24-3p in HBV-related hepatocellular carcinoma
Meng, F., Wang, W., & Jia, W. (2014) · Medical Oncology · doi:10.1007/s12032-014-0177-3 · Cited by 63
Wang, W., Bian, H., Li, F., Li, X., Zhang, D., Sun, S., Song, S., Zhu, Q., Ren, W., Qin, C., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2753-8 · Cited by 63
Cao, Y., Chen, J., Wang, D., Peng, H., Tan, X., Xiong, D., Huang, A., & Tang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.5642 · Cited by 59
Ghosh, A. K., Ghosh, A., Datta, S., Dasgupta, D., Das, S., Ray, S., Gupta, S. C., Datta, S., Chowdhury, A., Chatterjee, R., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29999 · Cited by 59
Song, J., Zhang, X., Ge, Q., Yuan, C., Chu, L., Liang, H., Liao, Z., Liu, Q., Zhang, Z., & Zhang, B. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27050 · Cited by 59
Fu, Y., Wei, X., Tang, C., Li, J., Liu, R., Shen, A., & Wu, Z. (2013) · Oncology Letters · doi:10.3892/ol.2013.1638 · Cited by 58
Cardin, R., Piciocchi, M., Sinigaglia, A., Lavezzo, E., Bortolami, M., Kotsafti, A., Cillo, U., Giacomo, Z., Claudia, M., Massimo, R., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-177 · Cited by 58
Long-term follow-up of chronic hepatitis C in patients diagnosed at a tertiary-care center
Forns, X., Ampurdanés, S., Sánchez‐Tapias, J. M., Guilera, M., Sans, M., Fueyo, A. S., Quintó, L., Joya, P., Bruguera, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00088-5 · Cited by 57
miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
Yen, C.-S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i22.5183 · Cited by 57
Salvi, A., Abeni, E., Portolani, N., Barlati, S., & Petro, G. D. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1716 · Cited by 56
Cardin, R., Piciocchi, M., Sinigaglia, A., Lavezzo, E., Bortolami, M., Kotsafti, A., Cillo, U., Zanus, G., Mescoli, C., Rugge, M., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-284 · Cited by 55
Fu, X., Tan, D., Hou, Z., Hu, Z., & Liu, G. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13078514 · Cited by 54
Dang, Y., Zeng, J., He, R., Rong, M., Luo, D., & Chen, G. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.4969 · Cited by 54
Qin, X., Chen, J., Wu, L., & Liu, Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.062 · Cited by 52
Sarkar, N., Panigrahi, R., Pal, A., Biswas, A., Singh, S., Kar, S. K., Bandopadhyay, M., Das, D., Saha, D., Kanda, T., et al. (2015) · Journal of Viral Hepatitis · doi:10.1111/jvh.12390 · Cited by 51
Self-citationMatsuda, Y., Ichida, T., Genda, T., Yamagiwa, S., Aoyagi, Y., & Asakura, H. (2003) · PubMed · Cited by 50
Autophagy-preferential degradation ofMIR224participates in hepatocellular carcinoma tumorigenesis
Lan, S., Wu, S., Zuchini, R., Lin, X., Su, I., Tsai, T., Lin, Y., Wu, C.-T., & Liu, H. (2014) · Autophagy · doi:10.4161/auto.29959 · Cited by 49
Jiang, X. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7197 · Cited by 49
Liu, H., Shi, W., Luan, F., Xu, S., Yang, F., Sun, W., Liu, J., & Ma, C. (2010) · Virus Genes · doi:10.1007/s11262-009-0441-3 · Cited by 47
Fu, N., Niu, X., Wang, Y., Du, H., Wang, B., Du, J., Li, Y., Wang, R., Zhang, Y., Zhao, S., et al. (2016) · PubMed · Cited by 47
Rashad, N. M., El‐Shal, A. S., Shalaby, S. M., & Mohamed, S. Y. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3298-8 · Cited by 46
Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes
Kwon, Y., Bose, S. K., Steele, R., Meyer, K., Bisceglie, A. M. D., Ray, R. B., & RAY, R. K. (2015) · Journal of Virology · doi:10.1128/jvi.01946-15 · Cited by 45
Gao, F., Sun, X., Wang, L., Tang, S., & Yan, C. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438522 · Cited by 44
Qiu, L., Wang, T., Xu, X., Wu, Y.-H., Tang, Q., & Chen, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122505 · Cited by 44
Ribes, J., Clèries, R., Rubió, A., Hernández, J. M., Mazzara, R., Madoz, P., Casanovas, T., Casanova, A., Gallén, M., Rodríguez, C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21882 · Cited by 42
Shaker, O. G., Alhelf, M., Morcos, G. N. B., & Elsharkawy, A. M. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.03.030 · Cited by 41
Liu, P., Zhang, H., Liang, X., Ma, H., Luan, F., Wang, B., Bai, F., Gao, L., & Ma, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4804 · Cited by 40
Hou, W., & Bonkovsky, H. L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.7836 · Cited by 40
Cui, S., Qian, Z., Chen, Y., Li, L., Li, P., & Ding, H. (2017) · Oncology Letters · doi:10.3892/ol.2017.7265 · Cited by 39
Wang, S., Cui, S., Zhao, W., Qian, Z., Liu, H., Chen, Y., Lv, F., & Ding, H.-G. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170910 · Cited by 39
Xing, T. J., Jiang, D., Huang, J., & Xu, Z. (2014) · Genetics and Molecular Research · doi:10.4238/2014.september.29.4 · Cited by 38
Singh, A. K., Manickavinayaham, S., & Kumar, V. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.238238 · Cited by 36
Shiffman, M. L. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50254 · Cited by 36
MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma
Cailing, S., & Xu, X. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.03.002 · Cited by 36
Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma
Tian, Y., & Ou, J. J. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3582-7 · Cited by 35
Moore, A., Wu, L., Chuang, J.-C., Sun, X., Luo, X., Gopal, P., Li, L., Celen, C., Zimmer, M., & Zhu, H. (2018) · Hepatology · doi:10.1002/hep.30487 · Cited by 35
Elfimova, N., Sievers, E., Eischeid, H., Kwiecinski, M., Noetel, A., Hunt, H., Becker, D., Frommolt, P., Quasdorff, M., Steffen, H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.023 · Cited by 34
Wu, S., Kanda, T., Imazeki, F., Nakamoto, S., Tanaka, T. U., Arai, M., Roger, T., Shirasawa, H., Nomura, F., & Yokosuka, O. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis363 · Cited by 34
Self-citationKong, X., Lv, Y., Shao, L., Nong, X.-Y., Zhang, G., Zhang, Y., Fan, H., Liu, M., Li, X., & Tang, H. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0949-y · Cited by 34
Parvaiz, F., Manzoor, S., Iqbal, J., Sarkar-Dutta, M., Imran, M., & Waris, G. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12361 · Cited by 33
Zou, S.-Q., Qu, Z.-L., Li, Z., & Wang, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i15.2259 · Cited by 33
Stroffolini, T., Esvan, R., Biliotti, E., Sagnelli, E., Gaeta, G. B., & Almasio, P. L. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24243 · Cited by 32
Hepatitis C Virus and Hepatocellular Carcinoma
Kanda, T., Yokosuka, O., & Omata, M. (2013) · Biology · doi:10.3390/biology2010304 · Cited by 31
Self-citationMicroRNA miR-122 as a Therapeutic Target for Oligonucleotides and Small Molecules
Thomas, M., & Deiters, A. (2013) · Current Medicinal Chemistry · doi:10.2174/0929867311320290009 · Cited by 30
Parvaiz, F., Manzoor, S., Iqbal, J., McRae, S., Javed, F., Ahmed, Q. L., & Waris, G. (2013) · Archives of Virology · doi:10.1007/s00705-013-1892-3 · Cited by 29
Al-Qahtani, A. A., Khalak, H. G., Alkuraya, F. S., Al-hamoudy, W., Alswat, K., Balwi, M. A. A., Abdulkareem, I. A., Sanai, F. M., & Abdo, A. A. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101724 · Cited by 28
Wu, S., Kanda, T., Nakamoto, S., Jiang, X., Nakamura, M., Sasaki, R., Haga, Y., Shirasawa, H., & Yokosuka, O. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2643 · Cited by 28
Self-citationAnalysis of MicroRNA Expression Profiles in Human Hepatitis B Virus-Related Hepatocellular Carcinoma
Li, J., Shi, W., Gao, Y., Yang, B., Xiang, J., Shan, S., Wang, Y., & Zhi, D. (2013) · Clinical Laboratory · doi:10.7754/clin.lab.2012.120901 · Cited by 26
Qadri, I., Choudhury, M., Rahman, S. M., Knotts, T. A., Janssen, R. C., Schaack, J. B., Iwahashi, M., Puljak, L., Simon, F. R., Kilic, G., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384743 · Cited by 24
Zhao, Q., Sun, X., Liu, C., Li, T., Cui, J., & Qin, C. (2018) · Oncology Letters · doi:10.3892/ol.2018.8117 · Cited by 24
Kojima, H., Kaita, K., Xu, Z., Ou, J.-H. J., Gong, Y., Zhang, M., & Minuk, G. Y. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00215-0 · Cited by 23
Prevention of hepatitis B virus-associated liver diseases by antiviral therapy
Tawada, A., Kanda, T., Imazeki, F., & Yokosuka, O. (2016) · Hepatology International · doi:10.1007/s12072-016-9720-y · Cited by 23
Self-citationKanda, T., Takahashi, K., Nakamura, M., Nakamoto, S., Wu, S., Haga, Y., Sasaki, R., Jiang, X., & Yokosuka, O. (2017) · Cancers · doi:10.3390/cancers9050043 · Cited by 22
Self-citationShiu, T., Shih, Y., Feng, A., Lin, H., Huang, S., Huang, T., Hsieh, C.-B., Chang, W., & Hsieh, T. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1518-4 · Cited by 20
LUO, L., CHEN, S., GONG, Q., Luo, N., Yu, L., Guo, J., & He, S. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1165 · Cited by 19
Devhare, P. B., Steele, R., Bisceglie, A. M. D., Kaplan, D. E., & Ray, R. B. (2016) · Gene Expression · doi:10.3727/105221616x693594 · Cited by 18
Chung, H., Chen, X., Yu, Y., Lee, H., Song, C. H., Choe, H., Lee, S., Kim, H., & Hong, S. (2017) · FEBS Open Bio · doi:10.1002/2211-5463.12357 · Cited by 17
von Olshausen, G., Quasdorff, M., Bester, R., Arzberger, S., Ko, C., van de Klundert, M. A. A., Zhang, K., Odenthal, M., Ringelhan, M., Niessen, C. M., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26103 · Cited by 17
Manickavinayaham, S., Singh, A. K., & Kumar, V. (2013) · Journal of Cell Science · doi:10.1242/jcs.126235 · Cited by 16
Liu, X., Zhang, Y., Wang, P., Wang, H., Su, H., Zhou, X., & Zhang, L. (2016) · Medical Science Monitor · doi:10.12659/msm.895943 · Cited by 16
Shehata, R. H., Abdelmoneim, S. S., Osman, O. A., Hasanain, A. F., Osama, A., Abdelmoneim, S. S., & Toraih, E. A. (2017) · PubMed Central · doi:10.22034/apjcp.2017.18.9.2395 · Cited by 16
Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic response
Sasaki, R., Kanda, T., Kato, N., Yokosuka, O., & Moriyama, M. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i12.898 · Cited by 10
Self-citationNakano, M., Kawaguchi, T., Nakamoto, S., Kawaguchi, A., Kanda, T., Imazeki, F., Kuromatsu, R., Sumie, S., Satani, M., Yamada, S., et al. (2013) · Oncology Reports · doi:10.3892/or.2013.2700 · Cited by 7
Self-citationAflatoxin and p53 abnormality in duck hepatocellular carcinoma
Imazeki, F., Yokosuka, O., Ohto, M., & Omata, M. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01364.x · Cited by 5
Self-citationp53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Self-citation
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
The multifaceted role of ferroptosis in liver disease
Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 665
Current epidemiology in hepatocellular carcinoma
Konyn, P., Ahmed, A., & Kim, D. (2021) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1991792 · Cited by 280
Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
D'souza, S., Lau, K. C., Coffin, C. S., & Patel, T. R. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i38.5759 · Cited by 257
Liu, X., Cai, Y., Zhang, Y., Zhang, H., Tian, S., Gong, Y., Song, Q., Chen, X., Ma, X., Wen, Y., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107526 · Cited by 39
Metadata
- Authors
- Kanda, T., Goto, T., Hirotsu, Y., Moriyama, M., & Omata, M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-18
- Volume
- 20
- Issue
- 6
- Pages
- 1358
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2921608255
- Cited by
- 280
- References
- 180
- FWCI
- 20.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.